Bone Biologics Corp. Return on Tangible Assets

Return on Tangible Assets of BBLG for past 10 years: annual, quarterly and twelve month trailing (TTM) including Return on Tangible Assets growth rates and interactive chart.


Highlights and Quick Summary

  • Annual Return on Tangible Assets for 2021 was -24.5% (a -283.8% decrease from previous year)
  • Annual Return on Tangible Assets for 2020 was 13.33% (a -97.87% decrease from previous year)
  • Annual Return on Tangible Assets for 2019 was 625.42% (a 1113.7% increase from previous year)
  • Twelve month Return on Tangible Assets ending September 30, 2022 was 9741.2% (a 26.75% increase compared to previous quarter)
  • Twelve month trailing Return on Tangible Assets increased by 49.06% year-over-year
Trailing Return on Tangible Assets for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
9741.2% 7685.15% 7111.45% 6534.93%
Visit stockrow.com/BBLG for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Return on Tangible Assets of Bone Biologics Corp.

Most recent Return on Tangible Assetsof BBLG including historical data for past 10 years.

Interactive Chart of Return on Tangible Assets of Bone Biologics Corp.

Bone Biologics Corp. Return on Tangible Assets for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 -24.5%
2020 13.33%
2019 625.42%
2018 51.53%
2017 4242.84%
2016 3232.01%

Business Profile of Bone Biologics Corp.

Sector: Healthcare
Industry: Medical Devices